On ECHEMI
Home > Drugs > Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
  • Founded in:

    1992-03-31
  • Country:

    China China
  • Address:

    No. 789, Xinluo Street, Jinan High-tech Development Zone
  • Tax NO.:

    913701006140705563
  • Registered Funds:

    90 million yuan
  • Website:

  • Email:

Related Drugs
Ketotifen Fumarate Nasal Drops
Each bottle contains 15 mg of ketotifen fumarate (calculated as ketotifen). The excipients are boric acid, borax, glycerin, disodium edetate, and ethylparaben.
Name Description Content CAS NO. Registered Holders
Ketotifen fumarate

It has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy.

More

It has both histamine H1 receptor antagonism and the effect of inhibiting the release of allergic reaction mediators. It not only has a strong anti-allergic effect, but also has a longer duration of efficacy.

15mg 34580-14-8 13
Pheniramine Maleate
Name Description Content CAS NO. Registered Holders
Pheniramine maleate

Extract from the above information

More

Extract from the above information

132-20-7 8
Sodium hyaluronate injection
The main ingredient of this product is sodium hyaluronate.
Name Description Content CAS NO. Registered Holders
Sodium hyaluronate

Sodium hyaluronate is the main component of synovial fluid and one of the components of cartilage matrix. It plays a lubricating role in the joint cavity, reducing friction between tissues, and at the same time plays an elastic role, buffering the effect of stress on articular cartilage, and exerting its due physiological function. Injecting high molecular weight, high concentration, and high viscoelastic sodium hyaluronate into the joint cavity can significantly improve the inflammatory response of synovial tissue, increase the sodium hyaluronate content in the synovial fluid, enhance the viscosity and lubrication function of the joint fluid, protect the articular cartilage, promote the healing and regeneration of articular cartilage, relieve pain, and increase joint mobility.

More

Sodium hyaluronate is the main component of synovial fluid and one of the components of cartilage matrix. It plays a lubricating role in the joint cavity, reducing friction between tissues, and at the same time plays an elastic role, buffering the effect of stress on articular cartilage, and exerting its due physiological function. Injecting high molecular weight, high concentration, and high viscoelastic sodium hyaluronate into the joint cavity can significantly improve the inflammatory response of synovial tissue, increase the sodium hyaluronate content in the synovial fluid, enhance the viscosity and lubrication function of the joint fluid, protect the articular cartilage, promote the healing and regeneration of articular cartilage, relieve pain, and increase joint mobility.

9067-32-7 33
Sodium hyaluronate injection
The main ingredient of this product is sodium hyaluronate
Name Description Content CAS NO. Registered Holders
Sodium hyaluronate

Sodium hyaluronate is a physiologically active substance widely found in animals and humans. It is distributed in human skin, synovial fluid, umbilical cord, aqueous humor, and vitreous body. This product is non-pyrogenic, non-antigenic, and does not cause inflammatory reactions. The high viscoelasticity and contour-like properties of high molecular weight sodium hyaluronate solution make it a protective tool and surgical tool during surgery. It is widely used in various ophthalmic surgeries and can assist instruments in gently separating, moving, and positioning tissues during surgery. In anterior segment surgery, after the drug solution is injected into the anterior chamber, the anterior chamber deepens to facilitate surgical operations, and can protect corneal cells and intraocular tissues, reduce postoperative complications, and improve the success rate of surgery.

More

Sodium hyaluronate is a physiologically active substance widely found in animals and humans. It is distributed in human skin, synovial fluid, umbilical cord, aqueous humor, and vitreous body. This product is non-pyrogenic, non-antigenic, and does not cause inflammatory reactions. The high viscoelasticity and contour-like properties of high molecular weight sodium hyaluronate solution make it a protective tool and surgical tool during surgery. It is widely used in various ophthalmic surgeries and can assist instruments in gently separating, moving, and positioning tissues during surgery. In anterior segment surgery, after the drug solution is injected into the anterior chamber, the anterior chamber deepens to facilitate surgical operations, and can protect corneal cells and intraocular tissues, reduce postoperative complications, and improve the success rate of surgery.

9067-32-7 33
Sodium chloride eye drops
This product contains 5.5 mg of sodium chloride (calculated as Cl) as the main ingredient per milliliter, and the auxiliary materials are: sodium hyaluronate, borax, and ethylparaben.
Name Description Content CAS NO. Registered Holders
Sodium chloride

Relieves dry eye symptoms

More

Relieves dry eye symptoms

5.5mg (based on Cl) 7647-14-5 43
Sodium hyaluronate

This product can relieve the symptoms of dry eyes.

More

This product can relieve the symptoms of dry eyes.

9067-32-7 33
Sodium tetraborate decahydrate

This product can relieve the symptoms of dry eyes.

More

This product can relieve the symptoms of dry eyes.

1303-96-4 15
ethyl salicylate

This product can relieve the symptoms of dry eyes.

More

This product can relieve the symptoms of dry eyes.

118-61-6 14
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.